CAH
Price
$164.93
Change
+$2.95 (+1.82%)
Updated
Jul 3 closing price
Capitalization
27.26B
32 days until earnings call
YI
Price
$7.43
Change
+$0.09 (+1.23%)
Updated
Jul 3 closing price
Capitalization
97.43M
Interact to see
Advertisement

CAH vs YI

Header iconCAH vs YI Comparison
Open Charts CAH vs YIBanner chart's image
Cardinal Health
Price$164.93
Change+$2.95 (+1.82%)
Volume$1.23M
Capitalization27.26B
111
Price$7.43
Change+$0.09 (+1.23%)
Volume$7.05K
Capitalization97.43M
CAH vs YI Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. YI commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Buy and YI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CAH: $164.93 vs. YI: $7.43)
Brand notoriety: CAH and YI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 52% vs. YI: 58%
Market capitalization -- CAH: $27.26B vs. YI: $97.43M
CAH [@Medical Distributors] is valued at $27.26B. YI’s [@Medical Distributors] market capitalization is $97.43M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 2 FA rating(s) are green whileYI’s FA Score has 0 green FA rating(s).

  • CAH’s FA Score: 2 green, 3 red.
  • YI’s FA Score: 0 green, 5 red.
According to our system of comparison, CAH is a better buy in the long-term than YI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 3 TA indicator(s) are bullish while YI’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 3 bullish, 5 bearish.
  • YI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CAH is a better buy in the short-term than YI.

Price Growth

CAH (@Medical Distributors) experienced а -0.11% price change this week, while YI (@Medical Distributors) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

CAH is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than YI($97.4M). CAH YTD gains are higher at: 40.995 vs. YI (19.262). CAH has higher annual earnings (EBITDA): 1.89B vs. YI (-238.88M). CAH has more cash in the bank: 4.59B vs. YI (699M). YI has less debt than CAH: YI (398M) vs CAH (4.72B). CAH has higher revenues than YI: CAH (216B) vs YI (14.7B).
CAHYICAH / YI
Capitalization27.3B97.4M28,029%
EBITDA1.89B-238.88M-792%
Gain YTD40.99519.262213%
P/E Ratio44.47N/A-
Revenue216B14.7B1,469%
Total Cash4.59B699M657%
Total Debt4.72B398M1,187%
FUNDAMENTALS RATINGS
CAH vs YI: Fundamental Ratings
CAH
YI
OUTLOOK RATING
1..100
3250
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
862
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (67) in the Medical Distributors industry is in the same range as YI (74) in the Drugstore Chains industry. This means that CAH’s stock grew similarly to YI’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is significantly better than the same rating for YI (100) in the Drugstore Chains industry. This means that CAH’s stock grew significantly faster than YI’s over the last 12 months.

CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as YI (100) in the Drugstore Chains industry. This means that CAH’s stock grew similarly to YI’s over the last 12 months.

CAH's Price Growth Rating (8) in the Medical Distributors industry is somewhat better than the same rating for YI (62) in the Drugstore Chains industry. This means that CAH’s stock grew somewhat faster than YI’s over the last 12 months.

CAH's P/E Growth Rating (92) in the Medical Distributors industry is in the same range as YI (100) in the Drugstore Chains industry. This means that CAH’s stock grew similarly to YI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHYI
RSI
ODDS (%)
Bearish Trend 4 days ago
49%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
46%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
58%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
46%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
44%
Bullish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
57%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARTY41.300.60
+1.47%
iShares Future AI & Tech ETF
KJUL29.560.03
+0.10%
Innovator Russell 2000 Pwr Bffr ETF™ Jul
HYSA15.15N/A
N/A
BondBloxx USD High Yld Bd Sect Rot ETF
TOTR40.41-0.09
-0.23%
T. Rowe Price Total Return ETF
CEF30.45-0.11
-0.36%
Sprott Physical Gold and Silver Trust

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+1.82%
COR - CAH
56%
Loosely correlated
+1.74%
MCK - CAH
52%
Loosely correlated
+1.96%
OMI - CAH
19%
Poorly correlated
-0.86%
EDAP - CAH
13%
Poorly correlated
+1.27%
YI - CAH
13%
Poorly correlated
+1.23%
More

YI and

Correlation & Price change

A.I.dvisor tells us that YI and SNYR have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YI and SNYR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YI
1D Price
Change %
YI100%
+1.23%
SNYR - YI
22%
Poorly correlated
N/A
HSIC - YI
11%
Poorly correlated
+0.26%
ZYXI - YI
9%
Poorly correlated
-10.78%
EDAP - YI
7%
Poorly correlated
+1.27%
MCK - YI
1%
Poorly correlated
+1.96%
More